Bioamber (BIOA) Tops Q4 EPS by 19c

Bioamber (NYSE: BIOA) reported Q4 EPS of ($0.20), $0.19 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $308 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Bioamber (BIOA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance